scholarly journals Prostaglandin-Endoperoxides and Cyclic 3′-5′-AMP in Platelets of Patients with Uremia

1977 ◽  
Author(s):  
F. R. Matthias ◽  
W. Palinski
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Adenylate Cyclase ◽  
Prostaglandin E1 ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Bleeding Tendency ◽  
Prostaglandin Endoperoxide ◽  
Uremic Patients

In platelets of normal donors and of patients with chronic renal failure the following determinations were performed: 1. prostaglandin-endoperoxide-formation after N-ethylmaleimide stimulation measured as malondialdehyde; 2. the c-AMP level according to the Gilman-method; 3. the adenylate-cyclase activity in response to prostaglandin E1; 4. aggregation in response to collagen.In comparison to’normal donores the prostaglandin-endoperoxide production was reduced in uremic patients. Plasma of uremics depresses the endoperoxide formation of normal platelets. The basal c-AMP level of platelets of’ patients with renal failure was not significantly changed, whereas the plasma c-AMP level was increased; the activation of the platelets adenylate-cyclase was impaired. The adenylate-cyclase activity of platelets from normal donors was reduced by uremic plasma.. The results are of interest as to the explanation of the bleeding tendency of uremic patients.

scholarly journals Prostaglandin-Endoperoxides and Cyclic 3′-5′-AMP in Platelets of Patients with Hypercoagulability and Shock

1977 ◽  
Author(s):  
F.R. Matthias
Keyword(s):  
Platelet Aggregation ◽  
Adenylate Cyclase ◽  
Platelet Function ◽  
Prostaglandin E1 ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Coagulation System ◽  
Prostaglandin Endoperoxide ◽  
Fibrin Formation

To get more insight in platelet function of patients suffering from insufficiency of the circulation together with intravascular fibrin formation as a sign of a stimulated coagulation system, the following parameters were determined: 1. the prostaglandin-endoperoxide formation of platelets in response to N-ethylmaleimide and collagen measured as malondialdehyde; 2. the c-AMP content of platelets and plasma according to the Gilman method; 3. the stimulating effect of prostaglandin E1 on the platelets adenylate-cyclase activity; 4. the collagen induced platelet aggregation.Platelet aggregation was reduced. The prostaglandin-endoperoxide formation was unchanged or elevatedin comparison to normal donors. Plasma c-AMP was increased, whereas the platelet c-AMP content was unaltered. Adenylate cyclase activity in response to prostaglandin E1 was reduced. Platelet function recovered concomitantly with the improvement of the circulation and the clotting parameters.

scholarly journals Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.

1994 ◽  
Vol 5 (1) ◽  
pp. 36-46
Author(s):  
M P Gawaz ◽  
G Dobos ◽  
M Späth ◽  
P Schollmeyer ◽  
H J Gurland ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Platelet Aggregation ◽  
Platelet Function ◽  
Uremic Toxin ◽  
Bleeding Tendency ◽  
Fibrinogen Receptor ◽  
Fibrinogen Binding ◽  
Uremic Patients ◽  
Stage Renal Disease

Impaired platelet function and a bleeding tendency are well-recognized complications of chronic renal failure. Because the fibrinogen receptor GPIIb-IIIa plays a central role in platelet aggregation and adhesion to the subendothelium, it was reasoned that a defect in this receptor may underlie the impaired platelet function in uremia. To test this hypothesis, the function of this receptor in the platelets of 11 uremic patients was studied. Aggregation studies were performed with flow cytometric techniques with anti-GPIIb-IIIa conformation-specific monoclonal antibodies (mAb) (anti-LIBS1 and anti-PMI-1). Antifibrinogen and antithrombospondin mAb were used to characterize fibrinogen binding to GPIIb-IIIa and the release of alpha-granules, respectively. Platelets from patients with chronic renal failure showed significantly decreased binding of conformation-dependent anti-LIBS1 mAb after ADP, phorbol myristate acetate, or RGD-peptide stimulation compared with normal controls, suggesting a defect related to the ability of the fibrinogen receptor to undergo a conformational change. Moreover, antifibrinogen and antithrombospondin binding to activated platelets were reduced in uremic patients, implying impairment of both ligand-binding and alpha-granule release. Hemodialysis partially restored GPIIb-IIIa function, which may account for the observed effects of this therapy in restoring platelet aggregation. These findings indicate that platelets of patients with chronic renal failure reveal an aggregation defect at least partially due to an intrinsic GPIIb-IIIa dysfunction and the presence of a putative uremic toxin that inhibits fibrinogen binding to GPIIb-IIIa.

Effect of lithium on prostaglandin E1− stimulated adenylate cyclase activity of human platelets

1974 ◽  
Vol 23 (4) ◽  
pp. 845-855 ◽  
Author(s):  
Wang Yao-Chun ◽  
Ghanshyam N. Pandey ◽  
Joe Mendels ◽  
Alan Frazer
Keyword(s):  
Adenylate Cyclase ◽  
Prostaglandin E1 ◽  
Human Platelets ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity

Regulation of Thrombocyte Adenylate Cyclase Activity in Terminal Renal Failure

1991 ◽  
Vol 66 (05) ◽  
pp. 623-624 ◽  
Author(s):  
Friedrich Lübbecke ◽  
Fritz Reinhard Matthias ◽  
Volker Wizemann
Keyword(s):  
Renal Failure ◽  
Adenylate Cyclase ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Terminal Renal Failure

scholarly journals The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes

1983 ◽  
Vol 214 (1) ◽  
pp. 231-234 ◽  
Author(s):  
J M Stein ◽  
B R Martin
Keyword(s):  
Adenylate Cyclase ◽  
Prostaglandin E1 ◽  
Platelet Membrane ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Dependent Inhibition ◽  
Dose Dependent Inhibition ◽  
Dose Dependent ◽  
Stimulation Of

Adenylate cyclase activity in platelet membrane preparations was measured in the presence of prostaglandin E1 (PGE1), GTP and a non-hydrolysable analogue of GDP, guanosine 5′-[beta-thio]diphosphate (GDP[beta S]). A dose-dependent inhibition of adenylate cyclase by GDP[beta S] was observed that could be reversed either by adding increased amounts of GTP or of PGE1.

scholarly journals Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of non-nuclear adenylate cyclase

1977 ◽  
Vol 162 (3) ◽  
pp. 473-482 ◽  
Author(s):  
D E Snider ◽  
C W Parker
Keyword(s):  
Enzyme Activity ◽  
Plasma Membrane ◽  
Adenylate Cyclase ◽  
Prostaglandin E1 ◽  
Plasma Membranes ◽  
Subcellular Fractions ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Marker Enzyme ◽  
Discontinuous Sucrose Gradient

Human peripheral lymphocytes were broken in a Dounce homogenizer and subcellular fractions enriched in plasma membranes or microsomal particles and mitochondria were isolated by centrifugation through a discontinuous sucrose gradient. Various agents that promote cyclic AMP accumulation in intact lymphocytes were compared in their ability to stimulate adenylate cyclase activity in the individual fractions. Plasma-membrane-rich fractions that were essentially free of other subcellular particles as judged by electron microscopy and marker enzyme measurements responded to fluoride, but weakly or not at all to prostaglandin E1 and other prostaglandins. Microsomal and mitochondrial-rich fractions responded markedly to both prostaglandin E1 and fluoride. In some, but not all, experiments phytohaemagglutinin produced a modest increase in enzyme activity in plasma-membrane-rich fractions. Catecholamines, histamine, parathyrin, glucagon and corticotropin produced little or no response. In the absence of theophylline, adenosine (1-10 micronM) stimulated basal enzyme activity, although at higher concentrations the responses to prostaglandin E1 and fluoride were inhibited. GTP (1-100 micronM) and GMP(5-1000 micronM) respectively inhibited or stimulated the response to fluoride, whereas the converse was true with prostaglandin E1.

scholarly journals Stimulation of hormone-responsive adenylate cyclase activity by a factor present in the cell cytosol

1980 ◽  
Vol 188 (2) ◽  
pp. 393-400 ◽  
Author(s):  
S MacNeil ◽  
A Crawford ◽  
H Amirrasooli ◽  
S Johnson ◽  
A Pollock ◽  
...  
Keyword(s):  
Enzyme Activity ◽  
Adenylate Cyclase ◽  
Prostaglandin E1 ◽  
Enzyme Activation ◽  
Cyclase Activity ◽  
Adenylate Cyclase Activity ◽  
Prostaglandin E ◽  
Human Articular Cartilage ◽  
Cell Cytosol ◽  
Stimulation Of

1. Homogenates of whole tissues were shown to contain both intracellular and extracellular factors that affected particulate adenylate cyclase activity in vitro. Factors present in the extracellular fluids produced an inhibition of basal, hormone- and fluoride-stimulated enzyme activity but factors present in the cell cytosol increased hormone-stimulated activity with relatively little effect on basal or fluoride-stimulated enzyme activity. 2. The existence of this cytosol factor or factors was investigated using freshly isolated human platelets, freshly isolated rat hepatocytes, and cultured cells derived from rat osteogenic sarcoma, rat calvaria, mouse melanoma, pig aortic endothelium, human articular cartilage chondrocytes and human bronchial carcinoma (BEN) cells. 3. The stimulation of the hormone response by the cytosol factor ranged from 60 to 890% depending on the tissue of origin of the adenylate cyclase. 4. In each case the behaviour of the factor was similar to the action of GTP on that particular adenylate cyclase preparation. 5. No evidence of tissue or species specificity was found, as cytosols stimulated adenylate cyclase from their own and unrelated tissues to the same degree. 6. In the human platelet, the inclusion of the cytosol in the assay of adenylate cyclase increased the rate of enzyme activity in response to stimulation by prostaglandin E1 without affecting the amount of prostaglandin E1 required for half-maximal stimulation or the characteristics of enzyme activation by prostaglandin E.

Sign in / Sign up

Export Citation Format

Share Document